FDA NDC Directory · JSON-LD · Markdown

MAXALT-MLT

NDC 78206-143 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic namerizatriptan benzoate
Labeler / ManufacturerOrganon LLC
Marketing categoryNew Drug Application (innovator) · App NDA020865
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRIZATRIPTAN BENZOATE (10 mg/1)
Marketing started20210601
Package count1

External sources

Source: openFDA. Public-domain (CC0).